Sandra L Dabora Selected Research

Sandra L Dabora Research Topics

10	Tuberous Sclerosis (Bourneville's Disease) 01/2013 - 10/2002
8	Neoplasms (Cancer) 01/2011 - 03/2005
5	Angiomyolipoma 01/2013 - 10/2002
4	Hamartoma 02/2010 - 10/2002
2	Kidney Diseases (Kidney Disease) 01/2013 - 02/2010
2	Angiofibroma 01/2011 - 01/2008
1	Brain Neoplasms (Brain Tumor) 01/2011
1	Cystadenoma 02/2010
1	Skin Manifestations 01/2008

10	trans-sodium crocetinate (crocetin)IBA 01/2013 - 10/2002
8	Sirolimus (Rapamycin)FDA Link 01/2013 - 03/2005
4	Interferon-gamma (Interferon, gamma)IBA 11/2007 - 10/2002
2	lipoarabinomannan (LAM)IBA 01/2013 - 01/2011
2	Vascular Endothelial Growth Factor DIBA 01/2013 - 01/2011
2	MTOR InhibitorsIBA 04/2009 - 11/2007
2	TOR Serine-Threonine KinasesIBA 04/2009 - 03/2007
2	temsirolimus FDA Link 11/2007 - 10/2006
1	CI 22IBA 01/2011
1	Biomarkers (Surrogate Marker)IBA 01/2011
1	Sunitinib (Sutent)FDA Link 02/2010
1	Asparaginase (Elspar)FDA Link 02/2010
1	Bevacizumab (Avastin)FDA Link 02/2010
1	Vincristine (Oncovin)FDA LinkGeneric 02/2010
1	Angiogenesis InhibitorsIBA 02/2010
1	Atorvastatin (Lipitor)FDA Link 04/2009
1	Tuberous Sclerosis Complex 1 ProteinIBA 04/2009
1	Tuberous Sclerosis Complex 2 ProteinIBA 04/2009
1	Sorafenib (BAY 43-9006)FDA Link 04/2009
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2009
1	Doxycycline (Periostat)FDA LinkGeneric 04/2009
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2009
1	Ointments (Pastes)IBA 01/2008
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2007